Chimeric Therapeutics Ltd activates Phase 1B of CHM 1101 glioblastoma clinical trial
Chimeric Therapeutics Ltd (ASX:CHM), the only clinical-stage cell therapy company on the ASX, is set to begin a Phase 1B clinical trial to test the safety...
Stay updated with breaking news from Cellular Therapy Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Chimeric Therapeutics Ltd (ASX:CHM), the only clinical-stage cell therapy company on the ASX, is set to begin a Phase 1B clinical trial to test the safety...
Miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Chimeric Therapeutics Ltd (ASX:CHM), the only ASX clinical-stage cell therapy company, welcomes the participation of leading US centre Sarah Cannon Research...
Star pediatrician Dr. David Margolis serves up a dose of laughter to his often direly sick young patients at Children’s Hospital of Wisconsin.
Treatment with exagamglogene autotemcel conferred clinically meaningful increases in fetal hemoglobin and total hemoglobin levels among patients with beta-thalassemia and sickle cell disease, results of two pivotal studies showed. The latest follow-up data from the CLIMB THAL-111 and CLIMB-SCD-121 trials — presented at American Society for Gene & Cell Therapy Annual Meeting —